Joel Greenblatt's position in Acadia Healthcare Company is currently worth $3.81 Million. That's 0.04% of their equity portfolio (540th largest holding). The first Acadia Healthcare Company trade was made in Q4 2016. Since then Joel Greenblatt bought shares eleven more times and sold shares on eleven occasions. The investor's estimated purchase price is $7.06 Million, resulting in a loss of 46%.